SMAD4 and colorectal carcinoma: Lastly, although we were able to identify recurrent CNA events in our mouse colorectal carcinoma model, roughly a third (nine of 28) of the tumors (despite having ≥30% tumor content) had no detectable aneuploidy or prioritized mutations/focal CN events or Smad4 loss.